Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer

about

Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer

Item

http://www.wikidata.org/entity/Q58555555

description

scientific article published on 08 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Breast cancer stem cell marker ...... nts with primary breast cancer

@en

Breast cancer stem cell marker ...... nts with primary breast cancer

@nl

type

Item

label

Breast cancer stem cell marker ...... nts with primary breast cancer

@en

Breast cancer stem cell marker ...... nts with primary breast cancer

@nl

prefLabel

Breast cancer stem cell marker ...... nts with primary breast cancer

@en

Breast cancer stem cell marker ...... nts with primary breast cancer

@nl

P1476

Breast cancer stem cell marker ...... nts with primary breast cancer

@en

P2093

Hailin Tang

http://www.w3.org/2001/XMLSchema#string

Jiali Wu

http://www.w3.org/2001/XMLSchema#string

Lu Yang

http://www.w3.org/2001/XMLSchema#string

Ning Lyu

http://www.w3.org/2001/XMLSchema#string

Weidong Wei

http://www.w3.org/2001/XMLSchema#string

Xiaoming Xie

http://www.w3.org/2001/XMLSchema#string

Xing Li

http://www.w3.org/2001/XMLSchema#string

Xinhua Xie

http://www.w3.org/2001/XMLSchema#string

P2860

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Prospective identification of tumorigenic breast cancer cells

Global cancer statistics, 2012

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency.

In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.

Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas.

Breast cancer stem cells: obstacles to therapy.

P304

3728-3735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.28032

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yanan Kong

P577

2018-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30405844

http://www.w3.org/2001/XMLSchema#string

P932

6215997

http://www.w3.org/2001/XMLSchema#string